Cover Image
Market Research Report

Global Nerve Repair Biomaterials Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

Published by Data Bridge Market Research Private Limited Product code 585604
Published Content info 230 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Nerve Repair Biomaterials Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
Published: January 1, 2017 Content info: 230 Pages
Description

Title:
Global Nerve Repair Biomaterials Market - Industry Trends and Forecast to 2024
Global Nerve Repair Biomaterials Market, By Product Type (Nerve Repair (Nerve Conduit, Nerve Graft (Allograft, Acellularized Allograft)), Nerve Protection (Nerve Protectors, Nerve Wrap), By Injury Type (Epineural Nerve Repair, Perineural Nerve Repair, Group Fascicular Repair), By End User (Hospital, Clinics, Ambulatory Trauma Centers), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) - Trends and Forecast to 2024.

The Global Nerve Repair Biomaterials Market is accounted to reach USD 775.59 million by 2024 from USD 326.71 million in 2016,it is growing at a CAGR of 11.5% in the forecast period 2017 to 2024.

With the increasing geriatric population, rising number of nerve injuries and nerve surgeries, increasing incidence of neurological disorders, favorable reimbursement policies, and increased government funding the global nerve repair biomaterials market is witnessing a rapid growth.

The key market players for Global Nerve Repair Biomaterials Market are listed below:

  • Stryker Corporation and Collagen Matrix, Inc.
  • AxoGen, Inc.,
  • Checkpoint Surgical, Inc.,
  • Polyganics
  • Synovis Micro Companies Alliance, Inc.

The market is further segmented into:

  • Injury Type
  • Application
  • Product Type
  • Geography

The global nerve repair biomaterials market is witnessing a rapid growth due to increasing geriatric population, high incidence of nerve injuries and neurological disorders, favorable reimbursement policies, and increased government funding. The demand for nerve repair biomaterials is increasing in hospitals followed by ambulatory trauma centres due to increasing aging population and rising number of nerve injuries and nerve surgeries.

Based on product type, the global nerve repair biomaterials market is segmented into nerve repair and nerve protection. In 2016, nerve repair dominated the market with a share of 74.5% and is expected to dominate the market in the future.

The global nerve repair biomaterials market is further segmented into nerve conduits and nerve grafts. In 2017, the nerve conduits segment is expected to account for the largest share. Nerve repair graft is further segmented into allograft and acellularized allograft. Nerve protection market is segmented into nerve protector and nerve wrap. In 2016, nerve protector market dominated the market with the largest share and is expected to dominate in the forecast period 2017-2024.

Based on the injury type, the nerve repair biomaterials market is segmented into epineural nerve repair, perineural nerve repair, and group fascicular repair.

On the basis of end user, the global nerve repair biomaterials market is categorized into hospitals, clinics, and ambulatory surgical centers. In 2017, hospitals segment is expected to dominate the market in the forecast period 2017-2024.

Based on geography, the Global Nerve Repair Biomaterials market is segmented into 11 geographical regions, such as,

  • North America,
  • South America,
  • Europe,
  • APAC,
  • MEA

Covered in this report:

The report covers the present scenario and the growth prospects of the Global Nerve Repair Biomaterials market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

Table of Contents

1. INTRODUCTION

  • 1.1. OVERVIEW OF THE GLOBAL NERVE REPAIR BIOMATERIALS MARKET
  • 1.2. CURRENCY AND PRICING
  • 1.3. LIMITATION
  • 1.4. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. KEY TAKEAWAYS
  • 2.2. ARRIVING AT THE GLOBAL NERVE REPAIR BIOMATERIALS SIZE
    • 2.2.1. VENDOR POSITIONING GRID
    • 2.2.2. TECHNOLOGY LIFE LINE CURVE
    • 2.2.3. MARKET TIME LINE
    • 2.2.4. MARKET GUIDE
    • 2.2.5. COMPANY POSITIONING GRID
    • 2.2.6. COMAPANY MARKET SHARE ANALYSIS
    • 2.2.7. MULTIVARIATE MODELLING
    • 2.2.8. STANDARDS OF MEASUREMENT
    • 2.2.9. TOP TO BOTTOM ANALYSIS
    • 2.2.10. VENDOR SHARE ANALYSIS
    • 2.2.11. DATA POINTS FROM KEY PRIMARY INTERVIEWS
    • 2.2.12. DATA POINTS FROM KEY SECONDARY DATABASES
  • 2.3. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: RESEARCH SNAPSHOT
  • 2.4. ASSUMPTIONS

3. MARKET OVERVIEW

  • 3.1. DRIVERS
  • 3.2. RESTRAINTS
  • 3.3. OPPORTUNITIES
  • 3.4. CHALLENGES

4. EXECUTIVE SUMMARY:

5. PREMIUM INSIGHTS

  • 5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPORTUNITIES
  • 5.2. TECHNOLOLGICAL ADVANCEMENTS
  • 5.3. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE GLOBAL NERVE REPAIR BIOMATERIALS MARKET
  • 5.4. MARKET REGULATORY SCENARIO BY COUNTRY
  • 5.5. INTERVIEW KEY INSIGHTS

6. GLOBAL NERVE REPAIR BIOMATERIALS MARKET, BY TYPE:

7. GLOBAL NERVE REPAIR BIOMATERIALS MARKET, BY INJURY TYPE:

8. GLOBAL NERVE REPAIR BIOMATERIALS MARKET, BY TECHNOLOGY:

9. GLOBAL NERVE REPAIR BIOMATERIALS MARKET, BY APPLICATION:

10. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: GEOGRAPHY:

11. GLOBAL NERVE REPAIR BIOMATERIALS MARKET, COMPANY PROFILES

  • 11.1. STRYKER CORPORATION AND COLLAGEN MATRIX, INC.
  • 11.2. AXOGEN, INC.,
  • 11.3. CHECKPOINT SURGICAL, INC.,
  • 11.4. POLYGANICS
  • 11.5. SYNOVIS MICRO COMPANIES ALLIANCE, INC
  • 11.6. COMPANY A
  • 11.7. COMPANY B
  • 11.8. COMPANY C
  • 11.9. COMPANY D
  • 11.10. COMPANY E
  • 11.11. COMPANY F
  • 11.12. COMPANY G
  • 11.13. COMPANY H
  • 11.14. COMPANY I
  • 11.15. COMPANY J
  • 11.16. COMPANY K
  • 11.17. COMPANY M
  • 11.18. COMPANY N
  • 11.19. COMPANY O

12. APPENDIX:

13. ABOUT DATA BRIDGE MARKET RESEARCH

  • 13.1. OVERVIEW OF THE GLOBAL MEDICAL NONWOVENS MARKET
Back to Top